SPI Healthcare 2264701 / CH0022647017
3’597.97
Pkt
5.14
Pkt
0.14
%
17:40:00
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu SPI Healthcare-Werten
| 05.06.23 | Novartis Neutral | UBS AG | |
| 05.06.23 | Roche Equal Weight | Barclays Capital | |
| 05.06.23 | Novartis Buy | Deutsche Bank AG | |
| 05.06.23 | Novartis Underweight | Barclays Capital | |
| 05.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 02.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 30.05.23 | Roche Sell | Deutsche Bank AG | |
| 26.05.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.05.23 | Roche Sell | Deutsche Bank AG | |
| 24.05.23 | Roche Equal Weight | Barclays Capital | |
| 19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.05.23 | Novartis Neutral | UBS AG | |
| 02.05.23 | Novartis Buy | Jefferies & Company Inc. | |
| 28.04.23 | Roche Sell | Deutsche Bank AG | |
| 27.04.23 | Roche Outperform | Credit Suisse Group | |
| 27.04.23 | Roche Sell | Deutsche Bank AG | |
| 27.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.04.23 | Novartis Underperform | Credit Suisse Group | |
| 26.04.23 | Novartis Underweight | Barclays Capital | |
| 26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 26.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.04.23 | Novartis Buy | Deutsche Bank AG | |
| 26.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.23 | Novartis Neutral | UBS AG | |
| 28.03.23 | Novartis Hold | Deutsche Bank AG | |
| 27.03.23 | Roche Equal Weight | Barclays Capital | |
| 27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
| 14.03.23 | Novartis Sell | Deutsche Bank AG | |
| 08.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.03.23 | Roche Neutral | UBS AG |